You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
領航醫藥生物科技(00399.HK)擬與華芯醫療器械組合營拓展中國一次性體檢用消化內窺鏡市場

格隆匯8月27日丨領航醫藥生物科技(00399.HK)宣佈,於2024年8月26日,公司就可能成立合營企業與策略夥伴湖南省華芯醫療器械有限公司訂立諒解備忘錄。

諒解備忘錄的主要條款如下:(i)公司及策略伴同意整合彼此的專業知識,併合作開拓及發展中國一次性體檢用消化內窺鏡市場;(ii)公司同意提供財務資源以支援合營企業的業務發展;(iii)策略伴同意向可能合營企業的業務提供相關專利技術支援;(iv)公司及策略伴各自同意委任三名員工成立聯合工作組以評估及審閲多項投資及合作機會,並進行研究,就投資及合作的條款進行討論;及(v)公司及策略伴同意討論可能合營企業於中國的可行性及發展,並致力於2024年10月31日或之前訂立具法律約束力的合營企業協議。

董事會相信,與策略伴的業務合作及可能成立合營企業符合集團把握醫療科技發展的策略,從而為本集團創造機會,擴闊其在醫療領域的業務範疇,並提升收入增長潛力。為達致上述目的,公司將繼續尋找集資機會,並擬將約一半集資款項撥作新業務發展之用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account